Neal Walker, President and CEO at Aclaris Therapeutics, Inc. (ACRS), sold 30,000 shares at $26.84 ($805K) on 2021-04-22, disclosed to the SEC on 2021-04-26.
Open-market sale of $805k ACRS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |